The Genomic Ascertainment Cohort is Open for Business
BY LESLEY EARL, NCI
The past decade has seen an explosion in the availability of genome-scale data—including chip genotypes, exome sequences, and even full-genome sequences—from hundreds of thousands of individuals. But even with all these data, it can be challenging for scientists to figure out the exact roles that particular genetic variants play in the development of diseases. Often, the problem is not the research itself, but the difficulty of finding enough people with the variant of interest.
Read more